Robert Meyer reports a stock award at Avalyn Pharma
By AlphaYouPublished Form 4
Meyer Robert J.
Reporting filer
Robert Meyer reports a stock award, not an open-market purchase or sale, in Avalyn Pharma Inc.. Form 4 filed Sep 17, 2026 lists 1 entry.
- Disclosed
- Sep 17, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) (derivative) | Meyer Robert J. | 2026-09-15 | A | Grant or award | 31182 | 0.00 | 31,182 | 2 days | Filed terms
|
Stock Option (Right to Buy) (derivative)
- Owner
- Meyer Robert J.
- Date
- 2026-09-15
- Code
- A
- Action
- Grant or award
- Quantity
- 31182
- Price
- 0.00
- Following holdings
- 31,182
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Stock Option (Right to Buy)
- conversion Or Exercise Price: 34.28
- transaction Date: 2026-09-15
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: false
- transaction Shares: 31182
- transaction Price Per Share: 0.00
- transaction Acquired Disposed Code: A
- id: F1
- expiration Date: 2036-09-14
- underlying Security Title: Common Stock
- underlying Security Shares: 31182
- shares Owned Following Transaction: 31182
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Meyer Robert J.: Director.
- F1: The shares underlying this option vest and become exercisable in three equal annual installments following the grant date, subject to the Reporting Person's continued service on each such vesting date.
Original sources
Prepared automatically from public filing data. Report a correction.